MBIO
Mustang Bio, Inc.
There isn't enough reported data to score MBIO yet.
MBIO Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
MBIO's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
MBIO PE Valuation
MBIO has no meaningful PE right now: it lost money over the past year.
MBIO Forward outlook
There aren't enough analyst estimates for MBIO to show an outlook.
MBIO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2024 | -$78.00 | +$314.00 |
| Q2 2024 | -$137.50 | +$328.00 |
| Q1 2024 | -$220.00 | +$288.00 |
| Q4 2023 | -$300.00 | +$262.50 |
| Q3 2023 | -$392.00 | +$208.00 |
| Q2 2023 | -$465.50 | +$142.00 |
| Q1 2023 | -$508.00 | +$77.00 |
| Q4 2022 | -$562.50 | +$7.50 |
MBIO lost $0.52 per share over the past year, a smaller loss than the year before.
MBIO Quarterly Revenue
MBIO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$876K | -$58K |
| Q2 2026 | -$967K | +$372K |
| Q1 2026 | -$1M | +$381K |
| Q4 2025 | -$1.7M | +$279K |
| Q3 2025 | -$818K | +$939K |
| Q1 2025 | -$1.4M | +$3.9M |
| Q4 2024 | -$2M | +$5.3M |
| Q3 2024 | -$1.8M | +$10.3M |
MBIO has burned cash in almost every quarter: −$5M over the past year, against −$6M the year before.
MBIO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +2.8K shares |
| 1 year | +68% | +2.7M shares |
| 3 years | +4044% | +6.6M shares |
| 5 years | +5669% | +6.6M shares |
| Available history | +13909% | +6.7M shares |
MBIO has 7M diluted shares, up 68% from a year ago.
MBIO Net Leverage
MBIO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
MBIO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.3 | Neutral |
| Stochastic | 24.2 | Neutral |
MBIO's weekly RSI is 39 (neutral) and its Stochastic is 24 (neutral).
MBIO PE vs Healthcare Sector
MBIO has no meaningful PE right now: it lost money over the past year.
MBIO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.42 | 9.5% above |
| 20 week MA | $0.52 | 12% below |
| 50 week MA | $0.73 | 37% below |
| 100 week MA | $1.59 | 71% below |
| 200 week MA | $64.1 | 99% below |
MBIO has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 99% below its 200-week average.
MBIO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2,865.0 | $3,135.0 | +9.4% |
| 2021 | $3,135.0 | $1,402.5 | -55% |
| 2022 | $1,402.5 | $288.2 | -79% |
| 2023 | $288.2 | $67.5 | -77% |
| 2024 | $67.5 | $9.20 | -86% |
| 2025 | $9.20 | $1.02 | -89% |
| 2026 YTD | $1.02 | $0.46 | -55% |
MBIO has finished five years in a row lower, and it's down 55% so far in 2026.